TickerLeague

Net Income for Revolution Medicines (RVMD)

According to Revolution Medicines's latest reported financial statements, the company's current net income (TTM) is -$1.37B USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

-$1.37B

YoY change

+88.5%

5Y CAGR

N/A

Peak year (2017)

-$31.13M

Cumulative net income

-$2.83B

Net Income history chart for Revolution Medicines (RVMD) from 2017 to 2025

Net Income history table for Revolution Medicines (RVMD) from 2017 to 2025

Fiscal yearPeriod endedReportedNet IncomeYoYYoY change
2025-$1.13B+88.5%-$531.21M
2024-$600.09M+37.5%-$163.73M
2023-$436.37M+75.5%-$187.66M
2022-$248.71M+32.9%-$61.61M
2021-$187.09M+73.0%-$78.93M
2020-$108.16M+126.9%-$60.49M
2019-$47.66M+14.1%-$5.88M
2018-$41.79M+34.3%-$10.66M
2017-$31.13M

Net Income values are taken from Revolution Medicines's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

The 2025 reading of Revolution Medicines (RVMD) net income is -$1.13B – surged 88.5% year-over-year.

-$31.13M stands as the all-time-high annual net income, posted in 2017, against a low of -$1.13B during 2025.

Revolution Medicines (RVMD) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $15.15B.

Revolution Medicines Net Income by Year

Revolution Medicines Net Income 2025: -$1.13B

Revolution Medicines net income in 2025 was -$1.13B, surged 88.5% from 2024. This figure represents the lowest annual value in the available history.

Revolution Medicines Net Income 2024: -$600.09M

Revolution Medicines net income in 2024 was -$600.09M, surged 37.5% from 2023.

Revolution Medicines Net Income 2023: -$436.37M

Revolution Medicines net income in 2023 was -$436.37M, surged 75.5% from 2022.

Revolution Medicines Net Income 2022: -$248.71M

Revolution Medicines net income in 2022 was -$248.71M, surged 32.9% from 2021.

Revolution Medicines Net Income 2021: -$187.09M

Revolution Medicines net income in 2021 was -$187.09M.

See more financial history for Revolution Medicines (RVMD).

Sector peers — Net Income

Companies in the same sector as Revolution Medicines, ranked by their latest net income.

CompanyNet IncomeSector
Novo Nordisk (NVO)$102.43BHealthcare
Johnson & Johnson (JNJ)$26.80BHealthcare
Eli Lilly (LLY)$20.64BHealthcare
Merck & Co. (MRK)$18.25BHealthcare
UnitedHealth Group (UNH)$12.06BHealthcare
AstraZeneca (AZN)$10.26BHealthcare
Amgen (AMGN)$7.71BHealthcare
AbbVie (ABBV)$4.23BHealthcare

Frequently asked questions

What is Revolution Medicines's net income?

Latest reported net income for Revolution Medicines (RVMD) is -$1.37B (period ending March 31, 2026).

How has Revolution Medicines net income changed year-over-year?

Revolution Medicines (RVMD) net income changed +88.5% year-over-year on the latest annual filing.

When did Revolution Medicines net income hit its highest annual value?

Revolution Medicines net income reached its highest annual value of -$31.13M in 2017.

What was Revolution Medicines net income in 2024?

Revolution Medicines (RVMD) net income in 2024 was -$600.09M.

What was Revolution Medicines net income in 2025?

Revolution Medicines (RVMD) net income in 2025 was -$1.13B.

RVMD Key Financials

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.